Arbutus Biopharma Earnings Estimate
| ABUS Stock | USD 4.11 0.28 6.38% |
Arbutus Biopharma Revenue Breakdown by Earning Segment
By analyzing Arbutus Biopharma's earnings estimates, investors can diagnose different trends across Arbutus Biopharma's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about 5.8 M in 2026, whereas Pretax Profit Margin is likely to drop (13.68) in 2026. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arbutus Biopharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Arbutus Biopharma Earnings per Share Projection vs Actual
About Arbutus Biopharma Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Arbutus Biopharma earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Arbutus Biopharma estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Arbutus Biopharma fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -1.2 B | -1.2 B | |
| Retained Earnings Total Equity | -1.1 B | -1 B | |
| Earnings Yield | (0.10) | (0.11) | |
| Price Earnings Ratio | (9.98) | (9.48) | |
| Price Earnings To Growth Ratio | 0.57 | 0.60 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.